logo

VNDA

Vanda Pharmaceuticals
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

VNDA fundamentals

Vanda Pharmaceuticals (VNDA) expects to report earnings on Jul 30, 2025, with estimated revenue of 54.77M (YoY +8.51%), and EPS at -- (YoY 0.00%).
Revenue estimate / YoY
54.77M
+8.51%
EPS estimate / YoY
--
0.00%
Report date
Jul 30, 2025
EPS
Revenue

Revenue & Expenses

VNDA has released its 2025 Q1 earnings report, with revenue of 50.04M, reflecting a YoY change of 5.43%, and net profit of -29.49M, showing a YoY change of -611.38%. The Sankey diagram below clearly presents VNDA's revenue sources and cost distribution.

Key Indicators

Vanda Pharmaceuticals (VNDA) key financial stats and ratios, covering profitability, financial health, and leverage.
Vanda Pharmaceuticals (VNDA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Vanda Pharmaceuticals (VNDA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Vanda Pharmaceuticals (VNDA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Vanda Pharmaceuticals (VNDA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Vanda Pharmaceuticals (VNDA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield